| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $589.0M | +19.8% |
| Cost of Revenue | $87.3M | +26.7% |
| R&D Expense | $12.7M | +0.5% |
| SG&A Expense | $193.8M | +9.0% |
| Operating Income | $257.8M | +32.1% |
| Pre-tax Income | $283.5M | +31.1% |
| Income Tax | $69.2M | +32.1% |
| Net Income | $214.3M | +30.8% |
| EPS (Basic) | $1.75 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $709.2M | +37.0% |
| Accounts Receivable | $126.5M | +93.2% |
| Inventory | $37.2M | +90.2% |
| Current Assets | $894.0M | +43.4% |
| Total Assets | $1.10B | +29.7% |
| Current Liabilities | $147.2M | +21.9% |
| Total Liabilities | $149.7M | +21.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $208.7M | -13.0% |
| Capital Expenditures | $58K | -89.6% |
| Investing Cash Flow | -$58K | +89.6% |
| Financing Cash Flow | -$17.0M | -112.1% |
| Free Cash Flow | $208.6M | -12.8% |
| +26.8% |
| EPS (Diluted) | $1.68 | +28.2% |
| Stockholders' Equity |
| $954.3M |
| +31.1% |